Health Care & Life Sciences » Healthcare Provision | Advanced Oncotherapy PLC

Advanced Oncotherapy PLC

Advanced Oncotherapy PLC
Stock Exchange London Stock Exchange
EPS
GBP0.13
Market Cap
GBP86.18 M
Shares Outstanding
200.43 M
Public Float
65.45 M

Profile

Address
4 Tenterden Street
London Greater London W1S 1TE
United Kingdom
Employees -
Website http://advancedoncotherapy.com
Updated 07/08/2019
Advanced Oncotherapy Plc engages in the development of proton therapy systems. It operates through the following business segments: Development of Proton Therapy-UK, Development of Proton Therapy-Switzerland, Development of Proton Therapy-USA, and Healthcare Related Properties-UK. The company was founded on September 15, 2005 and is headquartered in London, the United Kingdom.

Financials

View All
Created with Highcharts 5.0.14Advanced Oncotherapy PLCNet Income. Fiscal year is January-December. All values GBP Thousands.3 3963 3965 6005 6005 8455 84510 36810 36813 66013 66021 10221 10220132014201520162017201805k10k15k20k25k
Created with Highcharts 5.0.14Advanced Oncotherapy PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.6868002626990000201320142015201620172018020406080

Michael Jeffrey Sinclair
Executive Chairman
Nicolas Serandour
Chief Executive Officer & Director